V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012184 | 330010362 | null | 72.5 | Neo-adjuvant (N) | 2013-09-07 | 2014-02-27 | Mifamurtide weeks 1-12 | Y | null | 330007345 | MIFAMURTIDE |
| 330012185 | 330003786 | 1.6 | 66.7 | Curative (C) | 2015-06-24 | 2015-06-26 | Methotrexate Intermed dose (1g/m2) | N | N | 330007346 | METHOTREXATE |
| 330012186 | 330008045 | 1.54 | 63.1 | Palliative (P) | 2016-02-23 | 2016-03-09 | Trial Unspecified | N | N | 330007347 | TRIAL |
| 330012187 | 330003792 | 1.61 | 60.1 | Curative (C) | 2015-10-16 | 2016-03-08 | METHOTREXATE | 02 | N | 330007358 | METHOTREXATE |
| 330012188 | 330003793 | 1.6 | 54.7 | Adjuvant (A) | 2014-07-01 | 2014-07-07 | METHOTREXATE | N | N | 330007359 | METHOTREXATE |
| 330012189 | 330003796 | 1.66 | 51.1 | Palliative (P) | 2017-05-21 | 2018-06-23 | Trial Unspecified | Y | null | 330007378 | TRIAL |
| 330012190 | 330008058 | null | 56.8 | Palliative (P) | null | 2015-02-20 | Doxorubicin 75mg/m2 | null | null | 330007427 | DOXORUBICIN |
| 330012191 | 330003813 | 1.85 | 85 | Curative (C) | 2017-01-22 | 2017-01-22 | EW EuroEwing 2012 Arm A VAI | N | N | 330007452 | TRIAL |
| 330012192 | 330008064 | 1.7 | 60.7 | null | 2016-05-15 | 2016-05-16 | Trial Unspecified | N | N | 330007467 | TRIAL |
| 330012193 | 330003821 | 1.6 | 64.4 | Neo-adjuvant (N) | 2015-01-09 | 2015-06-29 | R2W trial | 01 | N | 330007479 | TRIAL |
| 330012194 | 330003825 | 1.77 | 11.5 | Adjuvant (A) | null | 2015-04-30 | Cisplatin | null | null | 330007485 | CISPLATIN |
| 330012195 | 330003828 | 1.61 | 82 | Neo-adjuvant (N) | 2014-01-08 | 2014-03-17 | Cisplatin | Y | N | 330007486 | CISPLATIN |
| 330012196 | 330003829 | 1.7 | 49.2 | Curative (C) | 2015-02-12 | 2015-02-26 | Trial Unspecified | N | Y | 330007491 | TRIAL |
| 330012197 | 330010381 | 1.77 | null | Neo-adjuvant (N) | 2017-07-10 | 2017-07-17 | MIFAMURTIDE | Y | Y | 330007503 | MIFAMURTIDE |
| 330012198 | 330003841 | 1.62 | 59 | Adjuvant (A) | 2014-08-17 | 2014-09-04 | EW EuroEwing 2012 Arm A VAI | N | N | 330007542 | TRIAL |
| 330012199 | 330003858 | 1.9 | null | Neo-adjuvant (N) | 2012-06-14 | 2012-10-23 | OST Mifamurtide | N | N | 330007587 | MIFAMURTIDE |
| 330012200 | 330012771 | 1.79 | 83 | Curative (C) | 2017-12-11 | 2018-01-06 | Trial Unspecified | N | N | 330007603 | TRIAL |
| 330012201 | 330003868 | 1.67 | 78.6 | Curative (C) | 2016-11-23 | 2016-11-24 | Mifamurtide weeks 1-12 | N | N | 330007616 | MIFAMURTIDE |
| 330012202 | 330008098 | 1.68 | 73.3 | Curative (C) | null | 2015-10-13 | OST Mifamurtide | null | null | 330007623 | MIFAMURTIDE |
| 330012203 | 330003878 | 1.78 | 61.45 | Adjuvant (A) | 2018-03-11 | 2018-03-12 | Mifamurtide weeks 13-36 | N | N | 330007660 | MIFAMURTIDE |
| 330012204 | 330003884 | 1.84 | 74.8 | Adjuvant (A) | 2014-11-25 | 2014-11-26 | MIFAMURTIDE | N | N | 330007672 | MIFAMURTIDE |
| 330012205 | 330008106 | 1.73 | 91 | Palliative (P) | 2015-10-16 | 2015-10-16 | EW EuroEwing 2012 Arm B IE | Y | N | 330007676 | TRIAL |
| 330012206 | 330003887 | 1.8 | 62.3 | Palliative (P) | null | 2017-06-09 | Doxorubicin 75mg/m2 | null | null | 330007685 | DOXORUBICIN |
| 330012207 | 330008110 | 0 | 54 | Adjuvant (A) | 2014-12-16 | 2015-03-16 | OST Euramos 1 Closed Trial - A | 01 | N | 330007703 | DOXORUBICIN |
| 330012208 | 330008112 | null | null | Adjuvant (A) | 2012-10-19 | 2013-04-09 | EW EuroEwing 2012 Arm B IE | N | null | 330007719 | TRIAL |
| 330012209 | 330003895 | 1.8 | null | Curative (C) | 2016-09-30 | 2016-10-07 | MIFAMURTIDE | N | Y | 330007724 | MIFAMURTIDE |
| 330012210 | 330003905 | 1.72 | null | Neo-adjuvant (N) | 2017-07-13 | 2017-08-29 | METHOTREXATE | N | N | 330007739 | METHOTREXATE |
| 330012211 | 330003910 | 0 | 68.7 | Neo-adjuvant (N) | 2017-02-16 | 2017-02-20 | Mifamurtide weeks 1-12 | N | N | 330007754 | MIFAMURTIDE |
| 330012212 | 330003914 | 0 | 81 | Curative (C) | 2014-02-22 | 2015-09-28 | DOXORUBICIN | N | N | 330007776 | DOXORUBICIN |
| 330012213 | 330011674 | 1.61 | null | Curative (C) | 2017-05-12 | 2017-05-12 | Cisplatin | N | Y | 330007831 | CISPLATIN |
| 330012214 | 330003924 | 0 | 96.3 | Curative (C) | 2018-02-17 | 2018-02-17 | Trial Unspecified | N | N | 330007879 | TRIAL |
| 330012215 | 330003930 | 0 | 50.3 | Not known (9) | 2016-10-11 | 2016-10-19 | Cisplatin 7 day | N | N | 330007899 | CISPLATIN |
| 330012216 | 330003935 | 1.78 | null | Palliative (P) | 2017-08-19 | 2017-12-27 | Trial Unspecified | N | Y | 330007924 | TRIAL |
| 330012217 | 330003938 | 1.62 | 64.3 | Palliative (P) | 2017-09-10 | 2018-02-18 | DOXORUBICIN | N | N | 330007962 | DOXORUBICIN |
| 330012218 | 330003941 | 0 | 57.8 | Curative (C) | 2013-07-22 | 2014-07-29 | DOXORUBICIN | 1 | N | 330007971 | DOXORUBICIN |
| 330012219 | 330003949 | 1.81 | null | Curative (C) | 2014-12-25 | 2014-12-25 | Mifamurtide weeks 1-12 | N | N | 330007988 | MIFAMURTIDE |
| 330012220 | 330003953 | 1.82 | 45.5 | Adjuvant (A) | null | 2016-12-02 | OST Euramos 1 Closed Trial - A | N | null | 330008012 | DOXORUBICIN |
| 330012221 | 330003955 | 1.58 | 11.2 | Disease modification (D) | 2016-07-28 | 2017-01-15 | Trial Unspecified | N | N | 330008037 | TRIAL |
| 330012222 | 330008153 | 1.61 | 55.8 | Neo-adjuvant (N) | 2018-09-21 | 2018-11-13 | METHOTREXATE | N | N | 330008049 | METHOTREXATE |
| 330012223 | 330010428 | 1.79 | 78.7 | Neo-adjuvant (N) | 2017-09-18 | 2017-09-18 | Trial Unspecified | N | N | 330008066 | TRIAL |
| 330012224 | 330010430 | 1.72 | 44.9 | Curative (C) | 2012-07-15 | 2015-01-30 | DOXORUBICIN | Y | N | 330008090 | DOXORUBICIN |
| 330012225 | 330003974 | null | 54.4 | Disease modification (D) | 2017-03-24 | 2017-03-24 | Trial Unspecified | null | null | 330008116 | TRIAL |
| 330012227 | 330003983 | 0 | 58.6 | Adjuvant (A) | null | 2016-12-16 | MIFAMURTIDE | null | null | 330008133 | MIFAMURTIDE |
| 330012228 | 330003985 | null | 16.3 | Palliative (P) | 2014-03-08 | 2014-03-11 | Trial Unspecified | N | null | 330008138 | TRIAL |
| 330012229 | 330003988 | 0 | null | Adjuvant (A) | 2014-08-03 | 2014-08-16 | MIFAMURTIDE | 1 | N | 330008146 | MIFAMURTIDE |
| 330012230 | 330003998 | 1.7 | 121.4 | Curative (C) | 2016-04-02 | 2016-04-05 | Methotrexate Intermed dose (1g/m2) | 02 | N | 330008194 | METHOTREXATE |
| 330012231 | 330004006 | 1.58 | 79.2 | Adjuvant (A) | 2016-10-11 | 2016-10-22 | Mifamurtide weeks 13-36 | Y | Y | 330008198 | MIFAMURTIDE |
| 330012232 | 330008185 | null | 53.6 | Palliative (P) | 2017-10-06 | 2017-10-14 | LAMB TRIAL | 02 | N | 330008235 | TRIAL |
| 330012233 | 330004021 | 1.93 | 11.5 | Palliative (P) | 2018-03-15 | 2018-03-15 | Trial Unspecified | 02 | N | 330008263 | TRIAL |
| 330012234 | 330004027 | 1.81 | 53.8 | Adjuvant (A) | null | 2017-04-15 | MIFAMURTIDE | N | null | 330008284 | MIFAMURTIDE |